Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Lymphoproliferative Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01458548
What this trial is testing

Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)

Who this might be right for
Post-transplantation Lymphoproliferative Disorder
Charite University, Berlin, Germany 70
Testing effectiveness (Phase 2)Study completedNCT02168101
What this trial is testing

Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 9
Testing effectiveness (Phase 2)Looking for participantsNCT06723457
What this trial is testing

Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Polymorphic Post-Transplant Lymphoproliferative DisorderRefractory B-Cell Non-Hodgkin Lymphoma
Reem Karmali 34
Testing effectiveness (Phase 2)Looking for participantsNCT07368634
What this trial is testing

Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Epstein-Barr Virus InfectionPost-Transplant Lymphoproliferative Disorder
Daihong Liu 18
Early research (Phase 1)Active Not RecruitingNCT06523699
What this trial is testing

Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 30
Not applicableLooking for participantsNCT07488728
What this trial is testing

Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis

Who this might be right for
EBV-associated T/NK-cell Lymphoproliferative DiseasesRefractory/Relapsed EBV-related Hemophagocytic LymphohistiocytosisLetermovir
Beijing Children's Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30
Large-scale testing (Phase 3)Study completedNCT01854567
What this trial is testing

P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma+1 more
Mesoblast, Ltd. 49
Testing effectiveness (Phase 2)Study completedNCT01310010
What this trial is testing

Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04904588
What this trial is testing

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMixed Phenotype Acute Leukemia+5 more
Center for International Blood and Marrow Transplant Research 300
Early research (Phase 1)WithdrawnNCT03768310
What this trial is testing

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

Who this might be right for
Non-hodgkin LymphomaAcute Lymphoblastic Leukemia
Baylor College of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT00167180
What this trial is testing

Post Transplant Donor Lymphocyte Infusion

Who this might be right for
Leukemia, Myeloid, ChronicLymphomasMultiple Myeloma+4 more
Masonic Cancer Center, University of Minnesota 57
Testing effectiveness (Phase 2)Study completedNCT02807883
What this trial is testing

Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00781170
What this trial is testing

Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplantation
Universitätsklinikum Hamburg-Eppendorf 20
Early research (Phase 1)Active Not RecruitingNCT00840853
What this trial is testing

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Chronic Lymphocytic Leukemia (CLL)Non Hodgkin's Lymphoma
Baylor College of Medicine 68
Not applicableActive Not RecruitingNCT01199562
What this trial is testing

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated Leukemia+151 more
City of Hope Medical Center 153
Testing effectiveness (Phase 2)Looking for participantsNCT07409454
What this trial is testing

MRD-Guided BCMA/CD3 Bispecific Antibody Treatment After Stem Cell Transplant for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04128501
What this trial is testing

Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting

Who this might be right for
Acute Bilineal LeukemiaAcute Biphenotypic LeukemiaAcute Myeloid Leukemia+3 more
M.D. Anderson Cancer Center 100
Early research (Phase 1)Study completedNCT00002787
What this trial is testing

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 22
Testing effectiveness (Phase 2)Study completedNCT00186628
What this trial is testing

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Who this might be right for
Leukemia, Mast-CellMantle-cell Lymphoma
Stanford University 36
Next Page